Early testing for Alzheimer’s | Science News



Support credible science journalism.

Subscribe to Science News today.


Early testing for Alzheimer’s

Spinal fluid compounds can predict in many cases whether people with mild cognitive impairments will develop the disease

4:15pm, July 21, 2009

Elderly people with mild cognitive losses are at a heightened risk of progressing to Alzheimer’s disease if they have a combination of telltale compounds in their spinal fluid, researchers report in the July 22/29 Journal of the American Medical Association.

By testing for a shortage of a sticky compound called amyloid-beta in the spinal fluid and for excess amounts of two kinds of a protein called tau, the scientists could identify people at greatest risk.

The test isn’t foolproof, and a positive reading still warns of a disease for which there is no cure. But scientists are heartened by this and earlier studies (SN: 9/20/03, p. 179)because Alzheimer’s disease is difficult to foresee and its early symptoms are often mistaken for routine cognitive losses caused by aging.

Niklas Mattsson of a Gothenburg University-affiliated hospital in Mölndal, Sweden, and an international group of scientists recruited 750 elderly pe

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content